Skip to main content

Table 2 Comparison of demographic, clinical and laboratorial data of SSc patients with and without anti-collagen V

From: Anti-collagen type v: a marker of early systemic sclerosis?

  Positive Anti-collagen V
N = 16
Negative Anti-collagen V
N = 65
p
Disease duration, years (SD) 8.8 (+ 5.1) 14.7 (+ 8.9) < 0.006
Early-SSc, n (%) 6/16 (38%) 12/65 (18%) 0.17
Rodnan Score, n (SD) 10.9 (+ 12.1) 10.5(+ 12.0) 0.82
Interstitial lung disease, n (%) 6/16 (38%) 43/65 (66%) 0.20
Pulmonary hypertension, n (%) 3/16 (19%) 13/65 (20%) 0.70
Esophageal disease, n (%) 8/16 (50%) 42/65 (65%) 0.80
ANA, n (%) 16/16 (100%) 64/65 (98%) 0.60
Anti-Scl 70, n (%) 5/16 (31%) 17/65 (26%) 0.68
Anticentromere, n (%) 3/16 (18%) 23/65 (35%) 0.24
  1. Values are expressed in n: numbers and percentage (%), or average ± standard deviation (SD). ANA Antinuclear antibodies, Anti-SCl70 anti-topoisomerase I